Today, a story about advances in treating the most deadly form of cancer: lung cancer. Those diagnosed will more than likely die within a year. Andy Bonnett, of Denver, was in his early 30's when he was told he had the disease. "I was actually quite shocked, and confused, and incredibly sad to hear those words," he said. That was two and a half years ago. Bonnett got very sick and progressed to the most advanced stage of the disease. But now, he's better, thanks to an experimental drug he's taking through the University of Colorado Cancer Center. It's called Crizotinib. And just 100 people on the planet are taking it. Thirty-five of them are doing so here in Colorado. For Andy Bonnett, and many others, the results have been extraordinary. Andy's with us along with Dr. Ross Camidge, the clinical director of UC-Denver's Lung Cancer program.
Promising New Cancer Drug at UC-Denver
Support Your Values With A Year-End Gift To CPR
Make your year-end donation to support the news, music and conversations you rely on.
Listen to The Taxman
A new podcast from CPR News takes an in-depth look at Colorado’s Taxpayer’s Bill Of Rights—TABOR— considered either the worst thing that’s happened to the state, or the best.
Most Viewed News
By Colorado Public Radio Staff
By David Hill